The report “Global Radiopharmaceuticals Market (PET/SPECT Imaging & Therapy) – Current Trends & Forecasts (2010 – 2015)”
analyzes the market for radiopharmaceuticals by isotopes, routes of
administration, and applications; and studies the major market drivers,
restraints, opportunities, and market trends for radiopharmaceuticals
market in North America (U.S. and Canada), Europe, Asia, Japan, and
Rest of the World.
Browse market data tables and in-depth TOC on “Global Radiopharmaceuticals Market (PET/SPECT Imaging & Therapy) – Current Trends & Forecasts (2010 – 2015)”
http://www.marketsandmarkets.com/Market-Reports/radiopharmaceuticals-market-417.html
Early buyers will receive 10% customization on reports.
Radiopharmaceuticals are drugs that contain radionuclides emitting radiation and are used for disease diagnosis and treatment. Developing countries such as China, India are making ways for the radiopharmaceutical market. The global radiopharmaceutical market for therapy and PET & SPECT imaging was valued at $3,213 million in 2010 and is expected to reach $4,734 million by 2015; growing at a CAGR of 8.1%. The PET & SPECT diagnosis accounted for the largest share -90%- of the global radiopharmaceutical market. Therapy accounts for 10% of the share of the total market, growing at a CAGR of 5.4% from 2011 to 2016.
“Agreements and collaborations” and “geographic expansion” are the two main strategies adopted by the players to stay competitive in this market. Although radiopharmaceuticals are predominately used for diagnosis, SPECT held a major share (72%) in 2010, PET is expected to grow at a CAGR of 13.1% from 2010 to 2015 to occupy 30% share in 2015.
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com
Contact:
Mr. Rohan
7557 Rambler Road,
Suite 727, Dallas, TX 75231
Tel: +1-888-6006-441
Email: sales@marketsandmarkets.com
MarketsandMarkets Blog
http://www.marketsandmarkets.com
http://twitter.com/marketsmarkets
Browse market data tables and in-depth TOC on “Global Radiopharmaceuticals Market (PET/SPECT Imaging & Therapy) – Current Trends & Forecasts (2010 – 2015)”
http://www.marketsandmarkets.com/Market-Reports/radiopharmaceuticals-market-417.html
Early buyers will receive 10% customization on reports.
Radiopharmaceuticals are drugs that contain radionuclides emitting radiation and are used for disease diagnosis and treatment. Developing countries such as China, India are making ways for the radiopharmaceutical market. The global radiopharmaceutical market for therapy and PET & SPECT imaging was valued at $3,213 million in 2010 and is expected to reach $4,734 million by 2015; growing at a CAGR of 8.1%. The PET & SPECT diagnosis accounted for the largest share -90%- of the global radiopharmaceutical market. Therapy accounts for 10% of the share of the total market, growing at a CAGR of 5.4% from 2011 to 2016.
“Agreements and collaborations” and “geographic expansion” are the two main strategies adopted by the players to stay competitive in this market. Although radiopharmaceuticals are predominately used for diagnosis, SPECT held a major share (72%) in 2010, PET is expected to grow at a CAGR of 13.1% from 2010 to 2015 to occupy 30% share in 2015.
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com
Contact:
Mr. Rohan
7557 Rambler Road,
Suite 727, Dallas, TX 75231
Tel: +1-888-6006-441
Email: sales@marketsandmarkets.com
MarketsandMarkets Blog
http://www.marketsandmarkets.com
http://twitter.com/marketsmarkets
No comments:
Post a Comment